logo

Iovance Biotherapeutics Inc (IOVA) Stock: 52-Week Performance Insights and Trading Volume

ZM Stock

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Iovance Biotherapeutics Inc’s current trading price is -23.46% away from its 52-week high, while its distance from the 52-week low is 337.07%. The stock’s price range for this time frame has been between $3.21 and $18.33. The trading volume of the company’s shares in the Healthcare reached around 6.51 million for the day, which was evidently lower than the average daily volume of 10.71 million over the last three months.

The market performance of Iovance Biotherapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $18.33 on 02/28/24, with the lowest value for the same timeframe being $3.21, recorded on 10/19/23.

How Financial Performance Impacts Market Capitalization

Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly rise of 81.97% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.92B and boasts a workforce of 557 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.62, with a change in price of +10.58. Similarly, Iovance Biotherapeutics Inc recorded 9,293,844 in trading volume during the last 100 days, posting a change of +306.67%.

How IOVA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.12.

IOVA Stock Stochastic Average

Iovance Biotherapeutics Inc’s raw stochastic average for the past 50 days is currently at 60.87%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 38.75%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.46% and 55.56%, respectively.

IOVA Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 72.57%. However, over the past six months, we’ve seen a weaker performance of 166.22%. The price of IOVA fallen by 42.15% over the last 30 days. And in the last five days, it has fallen by -7.09%.